Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Relief Sought for Small Retailers as GST 2.0 Sparks Losses in Pharma Trade

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive

Susmita Roy14 Sept 2025 2:00 PM IST

New Delhi: In a coordinated move to ensure patients benefit from the recent GST rate cut on drugs and medical devices effective 22nd September 2025,...

Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact

Sun Pharma Secures Interim Court Relief In URSOCOL Trademark Dispute

Susmita Roy14 Sept 2025 2:00 PM IST

New Delhi: In a relief to Sun Pharma Laboratories Limited, the Bombay High Court has granted an interim injunction restraining Rambos Lifesciences...

CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific

Susmita Roy14 Sept 2025 11:30 AM IST

New Delhi: Noting that the drug product is approved in the country of origin, the Subject Expert Committee (SEC), functional under the Central Drugs...

Fixed Dose Combination of Metformin-Voglibose Now CDSCO Approved

Susmita Roy13 Sept 2025 6:20 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has clarified that the fixed-dose combination (FDC) of Voglibose 0.2 mg and...

Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus' Phase III CT Waiver Request for Voclosporin

Susmita Roy13 Sept 2025 6:13 PM IST

New Delhi: Citing lack of sufficient efficacy and safety data to prove that the dose requirement in the Indian population is adequate, the Subject...

Assault upon a Medical Professional Jeopardises the Treatment of Patients Needing Urgent Care: Delhi HC

Delhi HC Refuses to Lift Ban on Medipol Pharma After Substandard Clarithromycin, Noscapine Supplied to Armed Forces

Susmita Roy12 Sept 2025 6:00 PM IST

New Delhi: The Delhi High Court has refused to stay the two-year debarment of Medipol Pharmaceutical India Pvt. Ltd. by the Directorate General of...

Chennai Court Acquits 2 After Alleged Nitravet Haul Found to Be Paracetamol

Susmita Roy12 Sept 2025 2:47 PM IST

New Delhi: A case projected as a major drug haul by the Chennai police collapsed in court after sealed packets, opened during trial, were found to...

PCI Opens Portal for Pharmacy Colleges to Seek 2026-27 Approval Extension

PCI Grants Final Window for Pharmacy Colleges to Submit Pending Data for 2025-26 Approval

Susmita Roy12 Sept 2025 2:40 PM IST

New Delhi: The Pharmacy Council of India (PCI) has granted a final opportunity to pharmacy institutions applying for approval under Section 12 (U/S...

Braille Labels, QR Code Voice Assistance on Drugs? CDSCO Seeks Stakeholder Comments

Susmita Roy11 Sept 2025 2:55 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has invited public comments on a proposal to make medicines more accessible to...

NPPA Notifies Ceiling Prices for IV Fluids in Advanced Packaging Formats, Details

Susmita Roy11 Sept 2025 2:12 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has notified the extension of separate ceiling prices for several IV fluid...

AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps

AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate

Susmita Roy11 Sept 2025 1:58 PM IST

New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drug Standard Control Organisation (CDSCO), has granted approval to the...

Patanjali challenges Delhi HC for disparaging chyawanprash ads

CDSCO Criminal Prosecution Against IndiaMART Put on Hold by Delhi HC Till Sept 17

Susmita Roy10 Sept 2025 9:51 PM IST

New Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) not to enforce its order initiating criminal...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok